FIELD: medicine.
SUBSTANCE: invention relates to a method of treating bile duct cancer, except for cystic duct adenocarcinoma, comprising administering 4-[3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide or its pharmacologically acceptable salt orally in dose of 1 to 100 mg a day to a patient in need thereof.
EFFECT: invention provides treatment of bile duct cancer, except for cystic duct adenocarcinoma.
3 cl, 9 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTITUMOUR THERAPEUTIC AGENT | 2016 |
|
RU2718048C2 |
| THERAPEUTIC AGENT FOR BILE DUCT CANCER | 2016 |
|
RU2712222C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING A TUMOUR | 2018 |
|
RU2750539C2 |
| THERAPEUTIC AGENT FOR TREATMENT OF HEPATOCELLULAR CARCINOMA | 2019 |
|
RU2777535C2 |
| THERAPEUTIC AGENT FOR TREATING BREAST CANCER | 2016 |
|
RU2730503C2 |
| REMEDY POTENTIATING ANTI-TUMOUR EFFECT, AND ANTI-TUMOUR REMEDY | 2004 |
|
RU2334517C2 |
| DRUG AND COMPOSITION FOR TREATMENT OF MALIGNANT TUMORS | 2017 |
|
RU2777595C2 |
| APPLICATION OF ERIBULIN IN CANCER TREATMENT | 2015 |
|
RU2699545C2 |
| PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING CANCER AND ITS METASTASES | 2006 |
|
RU2401662C2 |
| IMPROVED THERAPEUTIC INDEX OF INHIBITORS AGAINST IMMUNE CHECKPOINT USING COMBINATION THERAPY INCLUDING PHY906 EXTRACT, SCUTELLARIA BAICALENSIS GEORGI (S) EXTRACT OR COMPOUND OF SUCH EXTRACTS | 2017 |
|
RU2753523C2 |
